Corinne Faivre-Finn 💙
@finn_corinne
French and European, Prof of Thoracic Radiation Oncology, Researcher, RCTs, phase 1 drug-RT, ePROM, RWE, NIHR Senior Investigator, mother of 2. Views are my own
ID: 2582454033
04-06-2014 13:54:29
4,4K Tweet
4,4K Takipçi
417 Takip Edilen
Thrilled to participate on this all-star panel of amazing friends and leaders! I'll be joined by Rajika Jindani, MD, MPH, MS, a surgical resident at Montefiore Health System Albert Einstein College of Medicine - Official who I am grateful to sponsor & mentor, as we focus on supporting the Next Generation and the call to "Sponsor Her".
Fascinating field of research which we are aiming to implement in radiation oncology in Manchester ! 👇RTphysics Manchester Manchester Cancer Research Centre The Christie NHS
The Lung Team at the Christie is currently recruiting in studies for patients with stage 4 ROS1+ NSCLC who have received at least one previous line of treatment. If interested, please email [email protected] BTOG The ROS1ders, Inc.
Looking forward to your #WCLC24 presentation Joe Y Chang
Nice paper Sarah ▶️ 'Beyond mean heart dose' ▶️provides a summary of existing evidence of dose limits to ❤️ substructues ▶️explains how dose limits vary according to different sites/RT techniques ▶️proposes plan optimisation solutions RTphysics Manchester pubmed.ncbi.nlm.nih.gov/39228181/
An apt title for this lecture by Professor McNair H A McNair 💙. A fantastic turnout for this celebration from family, friends, colleagues and so many more. Standing ovation at the end for the well deserved prof. 👏🏻
T-1.5 days until IASLC #WCLC24 And here are your Social Media Ambassadors- the IASLC communications committee🔊 Follow these folks to track the best in thoracic onc in San Diego☀️ Matthew Smeltzer Stephen V Liu, MD Charu Aggarwal, MD, MPH, FASCO Aakash Desai, MD, MPH Dusty Joy Donaldson Narjust Florez, MD, FASCO RadOncResearch
At The Christie NHS we have already moved beyond heart dose ➡️ dose limit to base of heart implemented in the routine setting in stage 1-3 NSCLC ➡️impact on survival/toxicity evaluated using rapid-learning methodology RTphysics Manchester clinicaloncologyonline.net/article/S0936-…
Great session Brendon Stiles So sorry to miss it as my flight will arrive too late #WCLC24
Excellent session highlighting that the UK is leading the way in early-phase trials combining drug-radiotherapy A standout example is the CONCORDE trial ➡️Platform trial incorporating multiple DDR inhibitors ➡️TITE-CRM Bayesian design ➡️Randomised controlled arm Leeds CTRU Cancer Research UK
Congratulations Gerard Walls 👏👏